| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $916,613 ) |
| | 2024 | 2024 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 11011 VIA FRONTERA | SAN DIEGO | CA | 92127-1752 | SAN DIEGO | USA | R01AI173109 | Broadly neutralizing SARS-CoV-2 peptidic knobs | 000 | 2 | NIH | 5/29/2024 | $921,025 |
| | 2024 | 2022 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 11011 VIA FRONTERA | SAN DIEGO | CA | 92127-1752 | SAN DIEGO | USA | R01AI087202 | Defining parameters to induce breadth in knockin mice expressing HIV bnAb precursors | 000 | 12 | NIH | 2/27/2024 | $0 |
| | 2024 | 2021 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 11011 VIA FRONTERA | SAN DIEGO | CA | 92127-1752 | SAN DIEGO | USA | R01HD088400 | Defining clinically relevant viral epitopes with cow antibodies | 000 | 5 | NIH | 2/22/2024 | $0 |
| | 2024 | 2021 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 11011 VIA FRONTERA | SAN DIEGO | CA | 92127-1752 | SAN DIEGO | USA | R01HD088400 | Defining clinically relevant viral epitopes with cow antibodies | 000 | 5 | NIH | 2/22/2024 | $0 |
| | 2024 | 2021 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 11011 VIA FRONTERA | SAN DIEGO | CA | 92127-1752 | SAN DIEGO | USA | R21AI144828 | Ultralong CDR3 antibodies targeting exhausted T cells | 000 | 2 | NIH | 3/9/2024 | -$1,392 |
| | 2024 | 2021 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 11011 VIA FRONTERA | SAN DIEGO | CA | 92127-1752 | SAN DIEGO | USA | R01GM105826 | Molecular and Structural Studies of Antibody Diversity Mechanisms | 000 | 9 | NIH | 4/16/2024 | -$3,020 |
|
| Issue Date FY: 2023 ( Subtotal = $1,912,942 ) |
| | 2023 | 2023 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 11011 VIA FRONTERA | SAN DIEGO | CA | 92127-1752 | SAN DIEGO | USA | R01AI141338 | Novel vaccine strategies to induce V2 apex-directed broad neutralizing antibodies | 001 | 5 | NIH | 6/22/2023 | $945,717 |
| | 2023 | 2023 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 11011 VIA FRONTERA | SAN DIEGO | CA | 92127-1752 | SAN DIEGO | USA | R01AI173109 | Broadly neutralizing SARS-CoV-2 peptidic knobs | 000 | 1 | NIH | 6/9/2023 | $967,225 |
|
| Issue Date FY: 2022 ( Subtotal = $1,685,362 ) |
| | 2022 | 2022 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R01AI087202 | Defining parameters to induce breadth in knockin mice expressing HIV bnAb precursors | 001 | 12 | NIH | 12/28/2021 | $278,475 |
| | 2022 | 2022 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 11011 VIA FRONTERA | SAN DIEGO | CA | 92127-1752 | SAN DIEGO | USA | R01AI087202 | Defining parameters to induce breadth in knockin mice expressing HIV bnAb precursors | 003 | 12 | NIH | 7/11/2022 | $0 |
| | 2022 | 2022 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R01AI141338 | Novel vaccine strategies to induce V2 apex-directed broad neutralizing antibodies | 002 | 4 | NIH | 6/8/2022 | $957,727 |
| | 2022 | 2022 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 11011 VIA FRONTERA | SAN DIEGO | CA | 92127-1752 | SAN DIEGO | USA | R01AI141338 | Novel vaccine strategies to induce V2 apex-directed broad neutralizing antibodies | 003 | 4 | NIH | 8/3/2022 | $132,040 |
| | 2022 | 2021 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 11011 VIA FRONTERA | SAN DIEGO | CA | 92127-1752 | SAN DIEGO | USA | R01AI141338 | Novel vaccine strategies to induce V2 apex-directed broad neutralizing antibodies | 001 | 3 | NIH | 2/28/2022 | $317,120 |
| | 2022 | 2021 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 11011 VIA FRONTERA | SAN DIEGO | CA | 92127-1752 | SAN DIEGO | USA | R21AI144828 | Ultralong CDR3 antibodies targeting exhausted T cells | 000 | 2 | NIH | 8/15/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $1,944,384 ) |
| | 2021 | 2021 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R01HD088400 | Defining clinically relevant viral epitopes with cow antibodies | 000 | 5 | NIH | 6/19/2021 | $176,446 |
| | 2021 | 2021 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R01HD088400 | Defining clinically relevant viral epitopes with cow antibodies | 000 | 5 | NIH | 6/19/2021 | $176,447 |
| | 2021 | 2021 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R21AI144828 | Ultralong CDR3 antibodies targeting exhausted T cells | 000 | 2 | NIH | 1/25/2021 | $234,525 |
| | 2021 | 2021 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R01AI141338 | Novel vaccine strategies to induce V2 apex-directed broad neutralizing antibodies | 001 | 3 | NIH | 8/10/2021 | $957,548 |
| | 2021 | 2021 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R01GM105826 | Molecular and Structural Studies of Antibody Diversity Mechanisms | 000 | 9 | NIH | 8/4/2021 | $399,418 |
|
| Issue Date FY: 2020 ( Subtotal = $1,131,586 ) |
| | 2020 | 2020 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R01HD088400 | Defining clinically relevant viral epitopes with cow antibodies | 002 | 4 | NIH | 6/24/2020 | $179,290 |
| | 2020 | 2020 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R01GM105826 | Molecular and Structural Studies of Antibody Diversity Mechanisms | 002 | 8 | NIH | 8/19/2020 | $399,418 |
| | 2020 | 2020 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R21AI144828 | Ultralong CDR3 antibodies targeting exhausted T cells | 000 | 1 | NIH | 2/11/2020 | $303,450 |
| | 2020 | 2020 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R01HD088400 | Defining clinically relevant viral epitopes with cow antibodies | 002 | 4 | NIH | 6/24/2020 | $179,291 |
| | 2020 | 2020 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R21AI144828 | Ultralong CDR3 antibodies targeting exhausted T cells | 001 | 1 | NIH | 9/16/2020 | -$303,450 |
| | 2020 | 2020 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R21AI144828 | Ultralong CDR3 antibodies targeting exhausted T cells | 001 | 1 | NIH | 9/16/2020 | $303,450 |
| | 2020 | 2019 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R01HD088400 | Defining clinically relevant viral epitopes with cow antibodies | 001 | 3 | NIH | 2/25/2020 | $70,137 |
| | 2020 | 2019 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R01GM105826 | Molecular and Structural Studies of Antibody Diversity Mechanisms | 000 | 7 | NIH | 6/30/2020 | $0 |
| | 2020 | 2018 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R01GM105826 | Molecular and Structural Studies of Antibody Diversity Mechanisms | 001 | 6 | NIH | 6/30/2020 | $0 |
| | 2020 | 2018 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R01GM105826 | Molecular and Structural Studies of Antibody Diversity Mechanisms | 001 | 6 | NIH | 6/30/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $1,334,171 ) |
| | 2019 | 2019 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R01GM105826 | Molecular and Structural Studies of Antibody Diversity Mechanisms | 006 | 7 | NIH | 7/24/2019 | $385,820 |
| | 2019 | 2019 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R01HD088400 | Defining clinically relevant viral epitopes with cow antibodies | 002 | 3 | NIH | 9/18/2019 | -$179,978 |
| | 2019 | 2019 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R01HD088400 | Defining clinically relevant viral epitopes with cow antibodies | 001 | 3 | NIH | 9/9/2019 | $359,955 |
| | 2019 | 2019 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R01HD088400 | Defining clinically relevant viral epitopes with cow antibodies | 002 | 3 | NIH | 9/18/2019 | $179,978 |
| | 2019 | 2018 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R01GM105826 | Molecular and Structural Studies of Antibody Diversity Mechanisms | 005 | 6 | NIH | 6/20/2019 | $137,718 |
| | 2019 | 2018 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R01GM105826 | Molecular and Structural Studies of Antibody Diversity Mechanisms | 005 | 6 | NIH | 6/20/2019 | $159,941 |
| | 2019 | 2018 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R01GM105826 | Molecular and Structural Studies of Antibody Diversity Mechanisms | 003 | 6 | NIH | 5/6/2019 | $142,709 |
| | 2019 | 2018 | APPLIED BIOMEDICAL SCIENCE INSTITUTE | 10929 TECHNOLOGY PL | SAN DIEGO | CA | 92127-1887 | SAN DIEGO | USA | R01GM105826 | Molecular and Structural Studies of Antibody Diversity Mechanisms | 003 | 6 | NIH | 5/6/2019 | $148,028 |
|
|
